Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in lab setting
Research team shares enhanced recovery pathway for complex spine surgery
31 August 2021Older people with abdominal fat and weak muscles are more likely to develop mobility problems
31 August 2021Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in lab setting
Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development of antiviral drugs to treat infected individuals.
